These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15238817)

  • 1. Effects of statin therapy on vascular dysfunction.
    Aikawa M
    Coron Artery Dis; 2004 Aug; 15(5):227-33. PubMed ID: 15238817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid lowering therapy in atherosclerosis.
    Aikawa M; Libby P
    Semin Vasc Med; 2004 Nov; 4(4):357-66. PubMed ID: 15861316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin withdrawal: clinical implications and molecular mechanisms.
    Cubeddu LX; Seamon MJ
    Pharmacotherapy; 2006 Sep; 26(9):1288-96. PubMed ID: 16945051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early use of statins in acute coronary syndromes.
    Spin JM; Vagelos RH; ;
    Curr Cardiol Rep; 2002 Jul; 4(4):289-97. PubMed ID: 12052268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
    Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
    Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of statin use on endothelial function: from bench to clinics.
    Martínez-González J; Badimon L
    Curr Pharm Des; 2007; 13(17):1771-86. PubMed ID: 17584107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early statin therapy in acute coronary syndromes.
    Kinlay S; Ganz P
    Semin Vasc Med; 2003 Nov; 3(4):419-24. PubMed ID: 15199449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should standard medical therapy for angina include a statin?
    Corti R; Fuster V
    Clin Cardiol; 2004 Oct; 27(10):547-51. PubMed ID: 15553303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolving role of statins in the management of atherosclerosis.
    Vaughan CJ; Gotto AM; Basson CT
    J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG CoA reductase inhibitors are related to improved systemic endothelial function in coronary artery disease.
    Järvisalo MJ; Toikka JO; Vasankari T; Mikkola J; Viikari JS; Hartiala JJ; Raitakari OT
    Atherosclerosis; 1999 Dec; 147(2):237-42. PubMed ID: 10559508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin therapy and the management of acute coronary syndromes.
    Langer A; Constance C; Fodor JG; Frohlich JJ; Grégoire J; Lau DC; Leiter LA; Mancini GB; Marr D; McPherson R; O'Neill BJ; Rabkin SW
    Can J Cardiol; 2003 Jul; 19(8):921-7. PubMed ID: 12876613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Can statins slow the process of vascular calcification? Possibilities of lipid-lowering therapy and pleiotropic effect by statin treatment].
    Iijima K; Ouchi Y
    Clin Calcium; 2010 Nov; 20(11):1719-28. PubMed ID: 21037393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using statins to treat inflammation in acute coronary syndromes: Are we there yet?
    Shishehbor MH; Patel T; Bhatt DL
    Cleve Clin J Med; 2006 Aug; 73(8):760-6. PubMed ID: 16913201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease.
    Rackley CE
    Clin Cardiol; 1996 Sep; 19(9):683-9. PubMed ID: 8874986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology.
    Ray KK; Cannon CP
    Curr Opin Lipidol; 2004 Dec; 15(6):637-43. PubMed ID: 15529022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic value of statins for vascular remodeling.
    Nagashima H; Kasanuki H
    Curr Vasc Pharmacol; 2003 Oct; 1(3):273-9. PubMed ID: 15320474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy--Part II: Clinical considerations for cardiovascular disease.
    Sadowitz B; Seymour K; Costanza MJ; Gahtan V
    Vasc Endovascular Surg; 2010 Aug; 44(6):421-33. PubMed ID: 20547576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.